Connor, Clark & Lunn Investment Management »

Caribou Biosciences shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $58k 31k 1.90
2023-06-30 $689k 162k 4.25
2023-03-31 $420k 79k 5.31
2022-12-31 $279k 44k 6.28

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Toronto Dominion Bk Ont Com New (TD)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Shopify Cl A Sub Vtg Shs (SHOP)
Bk Nova Cad (BNS)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Canadian Pacific Kansas City (CP)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Caribou Biosciences

Pfizer
Vanguard Group
Vanguard Capital Management
Renaissance Technologies
Kynam Capital Management
BlackRock
Two Sigma Investments
Bank of America Corporation
Standard Life Aberdeen
Marshall Wace
Millennium Management
Susquehanna International
Geode Capital Management
Partner Fund Management
Mackenzie Financial

View all funds holding Caribou Biosciences